论文部分内容阅读
1992年1月～1996年1月,我们用放射免疫法测定70例恶性淋巴瘤患者血清β_2-m值,并对治疗前后其值的变化进行追踪测定。现报道如下。 对象和方法 一、对象:诊断明确的恶性淋巴瘤患者70例（女22,男48）。年的31.3±11.2（14～72）岁。均经手术或淋巴结活检病理诊断证实。其中何杰金氏病（HL）23例,非何杰金氏病（NHL）47例。另取30例健康体检正常成年人血清β_2-m值作对照。 二、方法:采用成都同位素应用技术研究所生产的放射免疫分析试剂盒,按说明书操作。测量仪器为上海原子核研究所生产的SN-682放免γ计数仪。 结果 结果见表1。
From January 1992 to January 1996, we used radioimmunoassay to measure the serum β 2 -m value in 70 patients with malignant lymphoma, and followed the change of their value before and after treatment. The report is as follows. Subjects and Methods I. Object: 70 patients diagnosed with malignant lymphoma (Female 22, Male 48). It is 31.3±11.2 (14-72) years old. All were confirmed by surgery or pathological diagnosis of lymph node biopsy. There were 23 cases of Hodgkin’s disease (HL) and 47 cases of non-Hodgkin’s disease (NHL). In addition, serum β 2 -m values of 30 normal healthy adults were taken as controls. Second, the method: using Chengdu Institute of Isotope Application Technology of radioimmunoassay kit, according to the instructions. The measuring instrument is the SN-682 radioimmunity counter manufactured by the Shanghai Institute of Nuclear Research. Results The results are shown in Table 1.